# PARTNER 3 Trial - Mitral Valve in Valve

> **NCT03193801** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Edwards Lifesciences** · enrollment: 53 (actual)

## Conditions studied

- Mitral Valve Insufficiency
- Mitral Valve Disease
- Mitral Valve Regurgitation
- Heart Failure

## Interventions

- **DEVICE:** Edwards SAPIEN 3 transcatheter valve, Model 9600TFX

## Key facts

- **NCT ID:** NCT03193801
- **Lead sponsor:** Edwards Lifesciences
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2018-02-01
- **Primary completion:** 2022-08-16
- **Final completion:** 2031-08
- **Target enrollment:** 53 (ACTUAL)
- **Last updated:** 2025-11-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03193801

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03193801, "PARTNER 3 Trial - Mitral Valve in Valve". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03193801. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*